Revolution Medicines Stock Analysis

Revolution Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.66. Revolution Medicines had not issued any dividends in recent years. Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California. Revolution Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 212 people. To find out more about Revolution Medicines contact Mark Goldsmith at 650 481 6801 or learn more at https://www.revmed.com.

Revolution Medicines Investment Alerts

Revolution Medicines Upcoming and Recent Events

Revolution Largest EPS Surprises

View All Earnings Estimates

Revolution Medicines Environmental, Social, and Governance (ESG) Scores

Revolution Stock Institutional Investors

Note, although Revolution Medicines' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Revolution Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.55 B.

Revolution Profitablity

Management Efficiency

Revolution Medicines has return on total asset (ROA) of (0.2856) % which means that it has lost $0.2856 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4718) %, meaning that it created substantial loss on money invested by shareholders. Revolution Medicines' management efficiency ratios could be used to measure how well Revolution Medicines manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.23. In addition to that, Return On Capital Employed is expected to decline to -0.27. At present, Revolution Medicines' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 10.6 M, whereas Other Assets are forecasted to decline to 0.95.

Technical Drivers

As of the 22nd of November, Revolution Medicines holds the Risk Adjusted Performance of 0.1176, coefficient of variation of 690.11, and Semi Deviation of 2.2. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Revolution Medicines, as well as the relationship between them. Please check Revolution Medicines information ratio, and the relationship between the downside deviation and value at risk to decide if Revolution Medicines is priced some-what accurately, providing market reflects its current price of 57.08 per share. Given that Revolution Medicines has jensen alpha of 0.2459, we recommend you to check out Revolution Medicines's recent market performance to make sure the company can sustain itself at a future point.

Revolution Medicines Price Movement Analysis

Revolution Medicines Insider Trading Activities

Revolution Medicines Predictive Daily Indicators

Revolution Medicines Corporate Filings

Revolution Medicines Forecast Models

Revolution Medicines' time-series forecasting models are one of many Revolution Medicines' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Revolution Medicines' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Revolution Medicines prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Revolution shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Revolution Medicines. By using and applying Revolution Stock analysis, traders can create a robust methodology for identifying Revolution entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Revolution analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Revolution analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Revolution Medicines stock analysis indicators help investors evaluate how Revolution Medicines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Revolution Medicines shares will generate the highest return on investment. By understating and applying Revolution Medicines stock analysis, traders can identify Revolution Medicines position entry and exit signals to maximize returns.

When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.